Immunopharmacology & Hematologic Pharmacology | Bleeding & Coagulation Disorders
Risk of recurrent venous thromboembolism is not increased in subjects with elevated albuminuria: results of a population based cohort study
Inge M van Schouwenburg*, Bakhtawar K Mahmoodi, Nic JGM Veeger, Hanneke C Kluin-Nelemans, Willem M Lijfering, Ron T Gansevoort
*Corresponding author: Inge M van Schouwenburg
Division of Haemostasis and Thrombosis, University Medical Center Groningen (UMCG), Groningen, Groningen, Netherlands
F1000Posters 2013, 4: 2 (poster) [English]
Poster [289.76 KB]
21st International Congress on Thrombosis 2010 , 6 - 9 Jul 2010, P000
Recently we identified elevated albuminuria as a risk factor for first venous thromboembolism (VTE). The risk of recurrent VTE (rVTE) in patients with elevated albuminuria is unknown, yet is an important issue for their clinical management.
Subjects known with higher albumin levels do not have an increased risk of rVTE. Therefore, prolonged anticoagulant treatment seems not necessary in such patients after first VTE.
No relevant competing interests disclosed.
Please note that most posters on this site present work that is preliminary in nature and has not been peer reviewed.
This poster is open access subject to the CC BY Creative Commons 3.0 License